Skip to main content

Table 2 PORT insertion characteristics and related complications in the study and control group patients

From: Impact of the COVID-19 pandemic on subcutaneous venous port-related complications in patients with cancer: a retrospective case–control study

  

Study group

Control group

p-value

n = 257

n = 168

Waiting time (days) median (IQR)

 

8 (7)

12 (7)

< 0.001

Inserting clinician, n (%)

   

0.004

Anaesthetist

245 (95.3)

168 (100)

 

Surgeon

12 (4.7)

0 (0)

 

Vein, n (%)

   

0.193

Internal jugular

251 (97.7)

160 (95.2)

 

Subclavian

3 (1.2)

4 (2.4)

 

Femoral

3 (1.2)

0 (0)

 

Unknown

0 (0)

4 (2.4)

 

Side, n (%)

   

0.343

Right

217 (84.4)

131 (78.0)

 

Left

40 (15.6)

31 (18.5)

 

Unknown

0 (0)

6 (3.6)

 

Anaesthetic, n (%)

LA

192 (74.7)

149 (88.7)

 

LA + sedation

64 (24.9)

15 (8.9)

< 0.001

General anaesthetic

1 (0.4)

1 (0.6)

Unknown

0 (0)

3 (1.8)

Ultrasound, n (%)

   

0.387

Yes

253 (98.4)

163 (97.0)

 

No

2 (0.8)

3 (1.8)

 

Unknown

2 (0.8)

2 (1.2)

 

Fluoroscopy, n (%)

   

0.059

Yes

253 (98.4)

152 (90.5)

 

No

2 (0.8)

6 (3.6)

 

Unknown

2 (0.8)

10 (6.0)

 

Arterial puncture, n (%)

Yes

1 (0.4)

1 (0.6)

1.0

Pneumothorax, n (%)

Yes

0 (0)

0 (0)

Haemothorax, n (%)

Yes

0 (0)

0 (0)

Haematoma, intervention required, n (%)

Yes

13 (5.1)

2 (1.2)

0.036

Antibiotics during insertion, n (%)

Yes

48 (18.7)

2 (1.2)

< 0.001

Procedure time, median (IQR)

 

33 (13)

26 (11)

< 0.001

  1. IQR interquartile range, LA local anaesthetic